NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Paradigm Peptide? Mail in a sample (US only) and let us test it.

Test my supply
56%
Finnrick rating
#9 of 500 ranked vendors
15 of 17 classifiable tests passed
methodology · Finnrick Standard
Finnrick analysis

Paradigm Peptide's rated catalog is narrow but mostly recent, with Tirzepatide and Retatrutide both showing passing identity and high purity in later labs. The record is dispersed: Tirzepatide is weighed down by an early large overfill and continued overfill lean, while Retatrutide's weakness is a recent missing batch ID.

methodology →
vendor intelligence report
Vendor Intelligence Report: Paradigm Peptide

We investigated who actually operates Paradigm Peptide — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages4 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Jul 2025: 31%5 Aug 2025: 28%11 Aug 2025: 30%11 Aug 2025: 32%11 Aug 2025: 34%11 Aug 2025: 35%4 Sep 2025: 38%4 Sep 2025: 40%4 Sep 2025: 42%22 Jan 2026: 46%22 Jan 2026: 47%22 Jan 2026: 49%22 Jan 2026: 51%22 Jan 2026: 52%26 Jan 2026: 54%26 Jan 2026: 55%30 Apr 2026: 55%17 Nov 2026: current 56%31%46%56%Jul 25Nov 26
Peptide testing

Ordered peptides from Paradigm Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Paradigm Peptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
30 Apr 2026
Fail
Retatrutide
lab nameView COA
27 Apr 2026
Incomplete
Retatrutide
lab nameView COA
26 Jan 2026
Pass
Tirzepatide
lab nameView COA
26 Jan 2026
Pass
Tirzepatide
lab nameView COA
22 Jan 2026
Pass
Tirzepatide
lab nameView COA
22 Jan 2026
Pass
Tirzepatide
lab nameView COA
22 Jan 2026
Pass
Tirzepatide
lab nameView COA
22 Jan 2026
Pass
Tirzepatide
lab nameView COA
22 Jan 2026
Pass
Tirzepatide
lab nameView COA
4 Sep 2025
Pass
Retatrutide
lab nameView COA
1-10 of 18

About Paradigm Peptide test results from Finnrick

Paradigm Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 18 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Paradigm Peptide peptides in this dataset are Tirzepatide (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 18 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Paradigm Peptide? Mail in a sample (US only) and let us test it.

Test my supply